Health Care & Life Sciences » Pharmaceuticals | Windtree Therapeutics Inc.

Windtree Therapeutics Inc.

Windtree Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.29
Market Cap
$136 M
Shares Outstanding
32.13 M
Public Float
6.57 M

Profile

Address
2600 Kelly Road
Warrington Pennsylvania 18976
United States
Employees -
Website http://www.windtreetx.com
Updated 07/08/2019
Windtree Therapeutics, Inc. engages in the manufacture and development of products for infants and respiratory diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The company was founded by Evan Myrianthopoulos and James S.

Financials

View All

Craig E. Fraser
President, Chief Executive Officer & Director
John R. Leone
Chairman